Cover Image
Market Research Report

Global Influenza Virus Vaccine (H1N1) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

Published by QYResearch Product code 929380
Published Content info 117 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Influenza Virus Vaccine (H1N1) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
Published: March 24, 2020 Content info: 117 Pages
Description

Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.

In 2019, the global Influenza Virus Vaccine (H1N1) market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Influenza Virus Vaccine (H1N1).

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Influenza Virus Vaccine (H1N1) market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Influenza Virus Vaccine (H1N1) market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Influenza Virus Vaccine (H1N1) market. Readers of the report can become informed about current and future trends of the global Influenza Virus Vaccine (H1N1) market and how they will impact market growth during the forecast period.

Geographic Segmentation

The report offers exhaustive assessment of different region-wise and country-wise Influenza Virus Vaccine (H1N1) markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE etc.

For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Influenza Virus Vaccine (H1N1) market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Market Segmentation by Type and by Application

The report includes a detailed analysis of leading and by Type and by Application segments of the global Influenza Virus Vaccine (H1N1) market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Influenza Virus Vaccine (H1N1) market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Influenza Virus Vaccine (H1N1) market is segmented into:

  • Intramuscular Vaccine
  • Nasal Spray Vaccine

Market Segment by Application, the Influenza Virus Vaccine (H1N1) market is segmented into:

  • 3 To 10 Years Old
  • 10 To 18 Years Old
  • Above 18 Years Old
  • Other

This report includes the following manufacturers; we can also add the other companies as you want.

  • CSL
  • NVS(Novartis)
  • Sanofi Pasteur
  • Medimmune
  • GSK
  • Baxter
  • Beijing Kexing Bio-Vaccine
  • Hualan Bio-Vaccine
  • Changchun Changsheng Bio-Technology
  • Beijing Tiantan Bio-Products
  • Jiangsu Yanshen Bio-Technology
  • Zhejiang Tianyuan Bio-Pharmaceutical
  • Dalian Yalifeng Bio-Pharmaceutical
  • Sinopharm

The study objectives are:

  • To analyze and research the global Influenza Virus Vaccine (H1N1) status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Influenza Virus Vaccine (H1N1) manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Influenza Virus Vaccine (H1N1) are as follows:

  • History Year: 2015-2020
  • Base Year: 2019
  • Estimated Year: 2020
Table of Contents

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Top Influenza Virus Vaccine(H1N1) Manufacturers Covered: Ranking by Revenue
  • 1.3. Market Segment by Type
    • 1.3.1. Global Influenza Virus Vaccine(H1N1) Market Size by Type: 2015 VS 2020 VS 2026(US$ Million)
    • 1.3.2. Intramuscular Vaccine
    • 1.3.3. Nasal Spray Vaccine
  • 1.4. Market Segment by Application
    • 1.4.1. Global Influenza Virus Vaccine(H1N1) Consumption by Application: 2015 VS 2020 VS 2026
    • 1.4.2. 3 To 10 Years Old
    • 1.4.3. 10 To 18 Years Old
    • 1.4.4. Above 18 Years Old
    • 1.4.5. Other
  • 1.5. Study Objectives
  • 1.6 Years Considered

2. Global Market Perspective

  • 2.1. Global Influenza Virus Vaccine(H1N1) Revenue(2015-2026)
    • 2.1.1. Global Influenza Virus Vaccine(H1N1) Revenue(2015-2026)
    • 2.1.2. Global Influenza Virus Vaccine(H1N1) Sales(2015-2026)
  • 2.2. Influenza Virus Vaccine(H1N1) Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
    • 2.2.1. Global Influenza Virus Vaccine(H1N1) Sales by Regions(2015-2020)
    • 2.2.2. Global Influenza Virus Vaccine(H1N1) Revenue by Regions(2015-2020)
  • 2.3. Global Top Influenza Virus Vaccine(H1N1) Regions(Countries) Ranking by Market Size
  • 2.4. Influenza Virus Vaccine(H1N1) Industry Trends
    • 2.4.1. Influenza Virus Vaccine(H1N1) Market Top Trends
    • 2.4.2. Market Drivers
    • 2.4.3. Influenza Virus Vaccine(H1N1) Market Challenges
    • 2.4.4. Porter's Five Forces Analysis
    • 2.4.5. Primary Interviews with Key Influenza Virus Vaccine(H1N1) Players: Views for Future

3. Competitive Landscape by Manufacturers

  • 3.1. Global Top Influenza Virus Vaccine(H1N1) Manufacturers by Sales(2015-2020)
    • 3.1.1. Global Influenza Virus Vaccine(H1N1) Sales by Manufacturers(2015-2020)
    • 3.1.2. Global Influenza Virus Vaccine(H1N1) Sales Market Share by Manufacturers(2015-2020)
    • 3.1.3. Global 5 and 10 Largest Manufacturers by Influenza Virus Vaccine(H1N1) Sales in 2019
  • 3.2. Global Top Manufacturers Influenza Virus Vaccine(H1N1) by Revenue
    • 3.2.1. Global Influenza Virus Vaccine(H1N1) Revenue by Manufacturers(2015-2020)
    • 3.2.2. Global Influenza Virus Vaccine(H1N1) Revenue Share by Manufacturers(2015-2020)
    • 3.2.3. Global Influenza Virus Vaccine(H1N1) Market Concentration Ratio(CR5 and HHI)
  • 3.3. Global Top Manufacturers by Company Type(Tier 1, Tier 2 and Tier 3)(based on the Revenue in Influenza Virus Vaccine(H1N1) as of 2019)
  • 3.4. Global Influenza Virus Vaccine(H1N1) Average Selling Price(ASP) by Manufacturers
  • 3.5. Key Manufacturers Influenza Virus Vaccine(H1N1) Plants/Factories Distribution and Area Served
  • 3.6. Date of Key Manufacturers Enter into Influenza Virus Vaccine(H1N1) Market
  • 3.7. Key Manufacturers Influenza Virus Vaccine(H1N1) Product Offered
  • 3.8. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Global Influenza Virus Vaccine(H1N1) Historic Market Review by Type(2015-2020)
    • 4.1.2. Global Influenza Virus Vaccine(H1N1) Sales Market Share by Type(2015-2020)
    • 4.1.3. Global Influenza Virus Vaccine(H1N1) Revenue Market Share by Type(2015-2020)
    • 4.1.4. Influenza Virus Vaccine(H1N1) Price by Type(2015-2020)
  • 4.1. Global Influenza Virus Vaccine(H1N1) Market Estimates and Forecasts by Type(2021-2026)
    • 4.2.2. Global Influenza Virus Vaccine(H1N1) Sales Forecast by Type(2021-2026)
    • 4.2.3. Global Influenza Virus Vaccine(H1N1) Revenue Forecast by Type(2021-2026)
    • 4.2.4. Influenza Virus Vaccine(H1N1) Price Forecast by Type(2021-2026)

5. Global Influenza Virus Vaccine(H1N1) Market Size by Application

  • 5.1. Global Influenza Virus Vaccine(H1N1) Historic Market Review by Application(2015-2020)
    • 5.1.2. Global Influenza Virus Vaccine(H1N1) Sales Market Share by Application(2015-2020)
    • 5.1.3. Global Influenza Virus Vaccine(H1N1) Revenue Market Share by Application(2015-2020)
    • 5.1.4. Influenza Virus Vaccine(H1N1) Price by Application(2015-2020)
  • 5.2. Global Influenza Virus Vaccine(H1N1) Market Estimates and Forecasts by Application(2021-2026)
    • 5.2.2. Global Influenza Virus Vaccine(H1N1) Sales Forecast by Application(2021-2026)
    • 5.2.3. Global Influenza Virus Vaccine(H1N1) Revenue Forecast by Application(2021-2026)
    • 5.2.4. Influenza Virus Vaccine(H1N1) Price Forecast by Application(2021-2026)

6. North America

  • 6.1. North America Influenza Virus Vaccine(H1N1) Breakdown Data by Company
  • 6.2. North America Influenza Virus Vaccine(H1N1) Breakdown Data by Type
  • 6.3. North America Influenza Virus Vaccine(H1N1) Breakdown Data by Application
  • 6.4. North America Influenza Virus Vaccine(H1N1) Breakdown Data by Countries
    • 6.4.1. North America Influenza Virus Vaccine(H1N1) Sales by Countries
    • 6.4.2. North America Influenza Virus Vaccine(H1N1) Revenue by Countries
    • 6.4.3. U.S.
    • 6.4.4. Canada

7. Europe

  • 7.1. Europe Influenza Virus Vaccine(H1N1) Breakdown Data by Company
  • 7.2. Europe Influenza Virus Vaccine(H1N1) Breakdown Data by Type
  • 7.3. Europe Influenza Virus Vaccine(H1N1) Breakdown Data by Application
  • 7.4. Europe Influenza Virus Vaccine(H1N1) Breakdown Data by Countries
    • 7.4.1. Europe Influenza Virus Vaccine(H1N1) Sales by Countries
    • 7.4.2. Europe Influenza Virus Vaccine(H1N1) Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. U.K.
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Influenza Virus Vaccine(H1N1) Breakdown Data by Company
  • 8.2. Asia Pacific Influenza Virus Vaccine(H1N1) Breakdown Data by Type
  • 8.3. Asia Pacific Influenza Virus Vaccine(H1N1) Breakdown Data by Application
  • 8.4. Asia Pacific Influenza Virus Vaccine(H1N1) Breakdown Data by Regions
    • 8.4.1. Asia Pacific Influenza Virus Vaccine(H1N1) Sales by Regions
    • 8.4.2. Asia Pacific Influenza Virus Vaccine(H1N1) Revenue by Regions
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. South Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Taiwan
    • 8.4.9. Indonesia
    • 8.4.10. Thailand
    • 8.4.11. Malaysia
    • 8.4.12. Philippines
    • 8.4.13. Vietnam

9. Latin America

  • 9.1. Latin America Influenza Virus Vaccine(H1N1) Breakdown Data by Company
  • 9.2. Latin America Influenza Virus Vaccine(H1N1) Breakdown Data by Type
  • 9.3. Latin America Influenza Virus Vaccine(H1N1) Breakdown Data by Application
  • 9.4. Latin America Influenza Virus Vaccine(H1N1) Breakdown Data by Countries
    • 9.4.1. Latin America Influenza Virus Vaccine(H1N1) Sales by Countries
    • 9.4.2. Latin America Influenza Virus Vaccine(H1N1) Revenue by Countries
    • 9.4.3. Mexico
    • 9.4.4. Brazil
    • 9.4.5. Argentina

10. Middle East and Africa

  • 10.1. Middle East and Africa Influenza Virus Vaccine(H1N1) Breakdown Data by Type
  • 10.2. Middle East and Africa Influenza Virus Vaccine(H1N1) Breakdown Data by Application
  • 10.3. Middle East and Africa Influenza Virus Vaccine(H1N1) Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Influenza Virus Vaccine(H1N1) Sales by Countries
    • 10.3.2. Middle East and Africa Influenza Virus Vaccine(H1N1) Revenue by Countries
    • 10.3.3. Turkey
    • 10.3.4. Saudi Arabia
    • 10.3.5. UAE

11. Company Profiles

  • 11.1. CSL
    • 11.1.1. CSL Corporation Information
    • 11.1.2. CSL Business Overview and Total Revenue(2019 VS 2018)
    • 11.1.3. CSL Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.1.4. CSL Influenza Virus Vaccine(H1N1) Products and Services
    • 11.1.5. CSL SWOT Analysis
    • 11.1.6. CSL Recent Developments
  • 11.2. NVS(Novartis)
    • 11.2.1. NVS(Novartis) Corporation Information
    • 11.2.2. NVS(Novartis) Business Overview and Total Revenue(2019 VS 2018)
    • 11.2.3. NVS(Novartis) Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.2.4. NVS(Novartis) Influenza Virus Vaccine(H1N1) Products and Services
    • 11.2.5. NVS(Novartis) SWOT Analysis
    • 11.2.6. NVS(Novartis) Recent Developments
  • 11.3. Sanofi Pasteur
    • 11.3.1. Sanofi Pasteur Corporation Information
    • 11.3.2. Sanofi Pasteur Business Overview and Total Revenue(2019 VS 2018)
    • 11.3.3. Sanofi Pasteur Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.3.4. Sanofi Pasteur Influenza Virus Vaccine(H1N1) Products and Services
    • 11.3.5. Sanofi Pasteur SWOT Analysis
    • 11.3.6. Sanofi Pasteur Recent Developments
  • 11.4. Medimmune
    • 11.4.1. Medimmune Corporation Information
    • 11.4.2. Medimmune Business Overview and Total Revenue(2019 VS 2018)
    • 11.4.3. Medimmune Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.4.4. Medimmune Influenza Virus Vaccine(H1N1) Products and Services
    • 11.4.5. Medimmune SWOT Analysis
    • 11.4.6. Medimmune Recent Developments
  • 11.5. GSK
    • 11.5.1. GSK Corporation Information
    • 11.5.2. GSK Business Overview and Total Revenue(2019 VS 2018)
    • 11.5.3. GSK Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.5.4. GSK Influenza Virus Vaccine(H1N1) Products and Services
    • 11.5.5. GSK SWOT Analysis
    • 11.5.6. GSK Recent Developments
  • 11.6. Baxter
    • 11.6.1. Baxter Corporation Information
    • 11.6.2. Baxter Business Overview and Total Revenue(2019 VS 2018)
    • 11.6.3. Baxter Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.6.4. Baxter Influenza Virus Vaccine(H1N1) Products and Services
    • 11.6.5. Baxter SWOT Analysis
    • 11.6.6. Baxter Recent Developments
  • 11.7. Beijing Kexing Bio-Vaccine
    • 11.7.1. Beijing Kexing Bio-Vaccine Corporation Information
    • 11.7.2. Beijing Kexing Bio-Vaccine Business Overview and Total Revenue(2019 VS 2018)
    • 11.7.3. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.7.4. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine(H1N1) Products and Services
    • 11.7.5. Beijing Kexing Bio-Vaccine SWOT Analysis
    • 11.7.6. Beijing Kexing Bio-Vaccine Recent Developments
  • 11.8. Hualan Bio-Vaccine
    • 11.8.1. Hualan Bio-Vaccine Corporation Information
    • 11.8.2. Hualan Bio-Vaccine Business Overview and Total Revenue(2019 VS 2018)
    • 11.8.3. Hualan Bio-Vaccine Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.8.4. Hualan Bio-Vaccine Influenza Virus Vaccine(H1N1) Products and Services
    • 11.8.5. Hualan Bio-Vaccine SWOT Analysis
    • 11.8.6. Hualan Bio-Vaccine Recent Developments
  • 11.9. Changchun Changsheng Bio-Technology
    • 11.9.1. Changchun Changsheng Bio-Technology Corporation Information
    • 11.9.2. Changchun Changsheng Bio-Technology Business Overview and Total Revenue(2019 VS 2018)
    • 11.9.3. Changchun Changsheng Bio-Technology Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.9.4. Changchun Changsheng Bio-Technology Influenza Virus Vaccine(H1N1) Products and Services
    • 11.9.5. Changchun Changsheng Bio-Technology SWOT Analysis
    • 11.9.6. Changchun Changsheng Bio-Technology Recent Developments
  • 11.10. Beijing Tiantan Bio-Products
    • 11.10.1. Beijing Tiantan Bio-Products Corporation Information
    • 11.10.2. Beijing Tiantan Bio-Products Business Overview and Total Revenue(2019 VS 2018)
    • 11.10.3. Beijing Tiantan Bio-Products Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.10.4. Beijing Tiantan Bio-Products Influenza Virus Vaccine(H1N1) Products and Services
    • 11.10.5. Beijing Tiantan Bio-Products SWOT Analysis
    • 11.10.6. Beijing Tiantan Bio-Products Recent Developments
  • 11.11. Jiangsu Yanshen Bio-Technology
    • 11.11.1. Jiangsu Yanshen Bio-Technology Corporation Information
    • 11.11.2. Jiangsu Yanshen Bio-Technology Business Overview and Total Revenue(2019 VS 2018)
    • 11.11.3. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.11.4. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine(H1N1) Products and Services
    • 11.11.5. Jiangsu Yanshen Bio-Technology SWOT Analysis
    • 11.11.6. Jiangsu Yanshen Bio-Technology Recent Developments
  • 11.12. Zhejiang Tianyuan Bio-Pharmaceutical
    • 11.12.1. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
    • 11.12.2. Zhejiang Tianyuan Bio-Pharmaceutical Business Overview and Total Revenue(2019 VS 2018)
    • 11.12.3. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.12.4. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine(H1N1) Products and Services
    • 11.12.5. Zhejiang Tianyuan Bio-Pharmaceutical SWOT Analysis
    • 11.12.6. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
  • 11.13. Dalian Yalifeng Bio-Pharmaceutical
    • 11.13.1. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
    • 11.13.2. Dalian Yalifeng Bio-Pharmaceutical Business Overview and Total Revenue(2019 VS 2018)
    • 11.13.3. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.13.4. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine(H1N1) Products and Services
    • 11.13.5. Dalian Yalifeng Bio-Pharmaceutical SWOT Analysis
    • 11.13.6. Dalian Yalifeng Bio-Pharmaceutical Recent Developments
  • 11.14. Sinopharm
    • 11.14.1. Sinopharm Corporation Information
    • 11.14.2. Sinopharm Business Overview and Total Revenue(2019 VS 2018)
    • 11.14.3. Sinopharm Influenza Virus Vaccine(H1N1) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.14.4. Sinopharm Influenza Virus Vaccine(H1N1) Products and Services
    • 11.14.5. Sinopharm SWOT Analysis
    • 11.14.6. Sinopharm Recent Developments

12. Supply Chain and Sales Channels Analysis

  • 12.1. Supply Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Influenza Virus Vaccine(H1N1) Sales Channels
    • 12.2.2. Influenza Virus Vaccine(H1N1) Distributors
  • 12.3. Influenza Virus Vaccine(H1N1) Customers

13. Estimates and Projections by Regions(2021-2026)

  • 13.1. Global Influenza Virus Vaccine(H1N1) Sales Forecast(2021-2026)
    • 13.1.1. Global Influenza Virus Vaccine(H1N1) Sales Forecast by Regions(2021-2026)
    • 13.1.2. Global Influenza Virus Vaccine(H1N1) Revenue Forecast by Regions(2021-2026)
  • 13.2. North America Market Size Forecast(2021-2026)
    • 13.2.1. North America Influenza Virus Vaccine(H1N1) Sales Forecast(2021-2026)
    • 13.2.2. North America Influenza Virus Vaccine(H1N1) Revenue Forecast(2021-2026)
    • 13.2.3. North America Influenza Virus Vaccine(H1N1) Size Forecast by County(2021-2026)
  • 13.3. Europe Market Size Forecast(2021-2026)
    • 13.3.1. Europe Influenza Virus Vaccine(H1N1) Sales Forecast(2021-2026)
    • 13.3.2. Europe Influenza Virus Vaccine(H1N1) Revenue Forecast(2021-2026)
    • 13.3.3. Europe Influenza Virus Vaccine(H1N1) Size Forecast by County(2021-2026)
  • 13.4. Asia Pacific Market Size Forecast(2021-2026)
    • 13.4.1. Asia Pacific Influenza Virus Vaccine(H1N1) Sales Forecast(2021-2026)
    • 13.4.2. Asia Pacific Influenza Virus Vaccine(H1N1) Revenue Forecast(2021-2026)
    • 13.4.3. Asia Pacific Influenza Virus Vaccine(H1N1) Size Forecast by Region(2021-2026)
  • 13.5. Latin America Market Size Forecast(2021-2026)
    • 13.5.1. Latin America Influenza Virus Vaccine(H1N1) Sales Forecast(2021-2026)
    • 13.5.2. Latin America Influenza Virus Vaccine(H1N1) Revenue Forecast(2021-2026)
    • 13.5.3. Latin America Influenza Virus Vaccine(H1N1) Size Forecast by County(2021-2026)
  • 13.6. Middle East and Africa Market Forecast
    • 13.6.1. Middle East and Africa Influenza Virus Vaccine(H1N1) Sales Forecast(2021-2026)
    • 13.6.2. Middle East and Africa Influenza Virus Vaccine(H1N1) Revenue Forecast(2021-2026)
    • 13.6.3. Middle East and Africa Influenza Virus Vaccine(H1N1) Size Forecast by County(2021-2026)

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
    • 15.1.2. Data Source
  • 15.2. Author Details
  • 15.3. Disclaimer

List of Tables

  • Table 1. Influenza Virus Vaccine (H1N1) Key Market Segments
  • Table 2. Ranking of Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Revenue (US$ Million) in 2019
  • Table 3. Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type 2021-2026 (K Doses) & (Million US$)
  • Table 4. Major Manufacturers of Intramuscular Vaccine
  • Table 5. Major Manufacturers of Nasal Spray Vaccine
  • Table 6. Global Influenza Virus Vaccine (H1N1) Market Share by Application 2019-2025 (K Doses)
  • Table 7. Global Influenza Virus Vaccine (H1N1) Market Size by Regions 2015-2020 (K Doses) & (Million US$)
  • Table 8. Global Influenza Virus Vaccine (H1N1) Sales by Regions 2015-2020 (K Doses)
  • Table 9. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Regions 2015-2020
  • Table 10. Global Influenza Virus Vaccine (H1N1) Revenue by Regions 2015-2020 (Million US$)
  • Table 11. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Regions 2015-2020
  • Table 12. Top Influenza Virus Vaccine (H1N1) Regions (Countries) Ranking by Market Size (US$ Million) in 2019
  • Table 13. Market Top Trends
  • Table 14. Influenza Virus Vaccine (H1N1) Key Drivers: Impact Analysis (2021-2026)
  • Table 15. Influenza Virus Vaccine (H1N1) Key Challenges
  • Table 16. Main Points Interviewed from Key Influenza Virus Vaccine (H1N1) Players: Views for Future
  • Table 17. Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers (2015-2020) (K Doses)
  • Table 18. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers (2015-2020)
  • Table 19. Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2015-2020) (Million US$)
  • Table 20. Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2015-2020)
  • Table 21. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2019)
  • Table 23. Key Manufacturers Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) (2015-2020) (US$/Dose)
  • Table 24. Key Manufacturers Influenza Virus Vaccine (H1N1) Plants/Factories Distribution
  • Table 25. Key Manufacturers Influenza Virus Vaccine (H1N1) Area Served
  • Table 26. Date of Key Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
  • Table 27. Key Manufacturers Influenza Virus Vaccine (H1N1) Product Type
  • Table 28. Mergers & Acquisitions, Expansion Plans
  • Table 29. Global Intramuscular Vaccine Sales and Revenue (2015-2020) (K Doses) & (Million US$)
  • Table 30. Global Nasal Spray Vaccine Sales and Revenue (2015-2020) (K Doses) & (Million US$)
  • Table 31. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2015-2020)
  • Table 32. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2015-2020)
  • Table 33. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Type (2015-2020)
  • Table 34. Global Influenza Virus Vaccine (H1N1) Price (K Doses) by Type (2015-2020)
  • Table 35. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2021-2026)
  • Table 36. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2021-2026)
  • Table 37. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Type (2021-2026)
  • Table 38. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2021-2026)
  • Table 39. Global Influenza Virus Vaccine (H1N1) Price (K Doses) by Type (2021-2026)
  • Table 40. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2015-2020)
  • Table 41. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2015-2020)
  • Table 42. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Application (2015-2020)
  • Table 43. Global Influenza Virus Vaccine (H1N1) Price by Application 2015-2020 (US$/Dose)
  • Table 44. Global Influenza Virus Vaccine (H1N1) Sales by Application (2015-2020) (K Doses)
  • Table 45. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2015-2020)
  • Table 46. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Application (2021-2026)
  • Table 47. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2021-2026)
  • Table 48. Global Influenza Virus Vaccine (H1N1) Price (K Doses) by Application (2021-2026)
  • Table 49. North America Influenza Virus Vaccine (H1N1) Sales by Company (2015-2020) (K Doses)
  • Table 50. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2015-2020)
  • Table 51. North America Influenza Virus Vaccine (H1N1) Sales by Type (2015-2020) (K Doses)
  • Table 52. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020)
  • Table 53. North America Influenza Virus Vaccine (H1N1) Sales by Application (2015-2020) (K Doses)
  • Table 54. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
  • Table 55. North America Influenza Virus Vaccine (H1N1) Sales by Countries (2015-2020) (K Doses)
  • Table 56. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Countries (2015-2020)
  • Table 57. North America Influenza Virus Vaccine (H1N1) Revenue by Countries (2015-2020) (Million US$)
  • Table 58. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Countries (2015-2020)
  • Table 59. Europe Influenza Virus Vaccine (H1N1) Sales by Company (2015-2020) (K Doses)
  • Table 60. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2015-2020)
  • Table 61. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2015-2020) (K Doses)
  • Table 62. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020)
  • Table 63. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2015-2020) (K Doses)
  • Table 64. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
  • Table 65. Europe Influenza Virus Vaccine (H1N1) Sales by Countries (2015-2020) (K Doses)
  • Table 66. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Countries (2015-2020)
  • Table 67. Europe Influenza Virus Vaccine (H1N1) Revenue by Countries (2015-2020) (Million US$)
  • Table 68. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Countries (2015-2020)
  • Table 69. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Regions (2015-2020) (K Doses)
  • Table 70. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Regions (2015-2020)
  • Table 71. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2015-2020) (K Doses)
  • Table 72. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020)
  • Table 73. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2015-2020) (K Doses)
  • Table 74. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
  • Table 75. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Countries (2015-2020) (K Doses)
  • Table 76. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Regions (2015-2020)
  • Table 77. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Regions (2015-2020) (Million US$)
  • Table 78. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Regions (2015-2020)
  • Table 79. Latin America Influenza Virus Vaccine (H1N1) Sales by Company (2015-2020) (K Doses)
  • Table 80. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2015-2020)
  • Table 81. Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2015-2020) (K Doses)
  • Table 82. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020)
  • Table 83. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2015-2020) (K Doses)
  • Table 84. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
  • Table 85. Latin America Influenza Virus Vaccine (H1N1) Sales by Countries (2015-2020) (K Doses)
  • Table 86. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Countries (2015-2020)
  • Table 87. Latin America Influenza Virus Vaccine (H1N1) Revenue by Countries (2015-2020) (Million US$)
  • Table 88. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Countries (2015-2020)
  • Table 89. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2015-2020) (K Doses)
  • Table 90. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020)
  • Table 91. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2015-2020) (K Doses)
  • Table 92. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
  • Table 93. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Countries (2015-2020) (K Doses)
  • Table 94. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Countries (2015-2020)
  • Table 95. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Countries (2015-2020) (Million US$)
  • Table 96. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Countries (2015-2020)
  • Table 97. CSL Company Details
  • Table 98. CSL Description and Business Overview
  • Table 99. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 100. CSL Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 101. CSL Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 102. CSL Recent Development
  • Table 103. NVS(Novartis) Company Details
  • Table 104. NVS(Novartis) Description and Business Overview
  • Table 105. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 106. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 107. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 108. NVS(Novartis) Recent Development
  • Table 109. Sanofi Pasteur Company Details
  • Table 110. Sanofi Pasteur Description and Business Overview
  • Table 111. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 112. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 113. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 114. Sanofi Pasteur Recent Development
  • Table 115. Medimmune Company Details
  • Table 116. Medimmune Description and Business Overview
  • Table 117. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 118. Medimmune Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 119. Medimmune Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 120. Medimmune Recent Development
  • Table 121. GSK Company Details
  • Table 122. GSK Description and Business Overview
  • Table 123. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 124. GSK Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 125. GSK Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 126. GSK Recent Development
  • Table 127. Baxter Company Details
  • Table 128. Baxter Description and Business Overview
  • Table 129. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 130. Baxter Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 131. Baxter Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 132. Baxter Recent Development
  • Table 133. Beijing Kexing Bio-Vaccine Company Details
  • Table 134. Beijing Kexing Bio-Vaccine Description and Business Overview
  • Table 135. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 136. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 137. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 138. Beijing Kexing Bio-Vaccine Recent Development
  • Table 139. Hualan Bio-Vaccine Company Details
  • Table 140. Hualan Bio-Vaccine Description and Business Overview
  • Table 141. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 142. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 143. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 144. Hualan Bio-Vaccine Recent Development
  • Table 145. Changchun Changsheng Bio-Technology Company Details
  • Table 146. Changchun Changsheng Bio-Technology Description and Business Overview
  • Table 147. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 148. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 149. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 150. Changchun Changsheng Bio-Technology Recent Development
  • Table 151. Beijing Tiantan Bio-Products Company Details
  • Table 152. Beijing Tiantan Bio-Products Description and Business Overview
  • Table 153. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 154. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 155. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 156. Beijing Tiantan Bio-Products Recent Development
  • Table 157. Jiangsu Yanshen Bio-Technology Company Details
  • Table 158. Jiangsu Yanshen Bio-Technology Description and Business Overview
  • Table 159. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 160. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 161. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 162. Jiangsu Yanshen Bio-Technology Recent Development
  • Table 163. Zhejiang Tianyuan Bio-Pharmaceutical Company Details
  • Table 164. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
  • Table 165. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 166. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 167. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 168. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
  • Table 169. Dalian Yalifeng Bio-Pharmaceutical Company Details
  • Table 170. Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
  • Table 171. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 172. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 173. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 174. Dalian Yalifeng Bio-Pharmaceutical Recent Development
  • Table 175. Sinopharm Company Details
  • Table 176. Sinopharm Description and Business Overview
  • Table 177. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
  • Table 178. Sinopharm Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020)
  • Table 179. Sinopharm Influenza Virus Vaccine (H1N1) Sales Market Share in Global Market
  • Table 180. Sinopharm Recent Development
  • Table 181. Influenza Virus Vaccine (H1N1) Distributors List
  • Table 182. Influenza Virus Vaccine (H1N1) Customers List
  • Table 183. Global Influenza Virus Vaccine (H1N1) Sales Forecast 2021-2026 (K Doses) & (Million US$)
  • Table 184. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type 2021-2026 (K Doses)
  • Table 185. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application 2021-2026 (K Doses)
  • Table 186. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Regions 2021-2026 (K Doses)
  • Table 187. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Regions 2021-2026 (Million US$)
  • Table 188. North America Influenza Virus Vaccine (H1N1) Sales Forecast by Countries 2021-2026 (K Doses)
  • Table 189. North America Influenza Virus Vaccine (H1N1) Revenue Forecast by Countries 2021-2026
  • Table 190. Europe Influenza Virus Vaccine (H1N1) Sales Forecast by Countries 2021-2026 (K Doses)
  • Table 191. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Countries 2021-2026
  • Table 192. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Forecast by Regions 2021-2026 (K Doses)
  • Table 193. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Forecast by Regions 2021-2026 (Million US$)
  • Table 194. Latin America Influenza Virus Vaccine (H1N1) Sales Forecast by Countries 2021-2026 (K Doses)
  • Table 195. Latin America Influenza Virus Vaccine (H1N1) Revenue Forecast by Countries 2021-2026 (Million US$)
  • Table 196. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Forecast by Regions 2021-2026 (K Doses)
  • Table 197. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Forecast by Regions 2021-2026 (Million US$)
  • Table 198. Research Programs/Design for This Report
  • Table 199. Key Data Information from Secondary Sources
  • Table 200. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Influenza Virus Vaccine (H1N1) Product Picture
  • Figure 2. Global Influenza Virus Vaccine (H1N1) Sales Market Shar by Type 2015-2026
  • Figure 3. Intramuscular Vaccine Figures
  • Figure 4. Nasal Spray Vaccine Figures
  • Figure 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2019 & 2026
  • Figure 6. 3 To 10 Years Old Use Case
  • Figure 7. 10 To 18 Years Old Use Case
  • Figure 8. Above 18 Years Old Use Case
  • Figure 9. Other Use Case
  • Figure 10. Influenza Virus Vaccine (H1N1) Report Years Considered
  • Figure 11. Global Influenza Virus Vaccine (H1N1) Market Size 2015-2026 (Million US$)
  • Figure 12. Global Influenza Virus Vaccine (H1N1) Sales 2015-2020 (K Doses)
  • Figure 13. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Regions 2015-2020
  • Figure 14. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Regions in 2019
  • Figure 15. Porter's Five Forces Analysis
  • Figure 16. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2019
  • Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Virus Vaccine (H1N1) Sales in 2019
  • Figure 18. Influenza Virus Vaccine (H1N1) Value Share by Manufacturers in 2019
  • Figure 19. Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers In 2019
  • Figure 20. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
  • Figure 21. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2015-2020)
  • Figure 22. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate by Type in 2015 & 2019
  • Figure 23. Global Influenza Virus Vaccine (H1N1) Market Share by Price Range (2015-2020)
  • Figure 24. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2015-2020)
  • Figure 25. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate by Application in 2015 & 2019
  • Figure 26. North America Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 27. U.S. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 28. Canada Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 29. Europe Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 30. Germany Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 31. France Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 32. U.K. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 33. Italy Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 34. Russia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 35. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 36. China Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 37. Japan Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 38. South Korea Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 39. India Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 40. Australia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 41. Taiwan Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 42. Indonesia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 43. Thailand Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 44. Malaysia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 45. Philippines Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 46. Vietnam Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 47. Latin America Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 48. Mexico Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 49. Brazil Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 50. Argentina Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 51. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 52. Turkey Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 53. Saudi Arabia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 54. UAE Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
  • Figure 55. CSL Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 56. NVS(Novartis) Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 57. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 58. Medimmune Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 59. GSK Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 60. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 61. Beijing Kexing Bio-Vaccine Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 62. Hualan Bio-Vaccine Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 63. Changchun Changsheng Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 64. Beijing Tiantan Bio-Products Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 65. Jiangsu Yanshen Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 66. Zhejiang Tianyuan Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 67. Dalian Yalifeng Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 68. Sinopharm Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 69. Influenza Virus Vaccine (H1N1) Value Chain
  • Figure 70. Channels of Distribution
  • Figure 71. Distributors Profiles
  • Figure 72. North America Influenza Virus Vaccine (H1N1) Sales Growth Rate Forecast (2021-2026) (K Doses)
  • Figure 73. North America Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 74. Europe Influenza Virus Vaccine (H1N1) Sales Growth Rate Forecast (2021-2026) (K Doses)
  • Figure 75. Europe Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 76. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Growth Rate Forecast (2021-2026) (K Doses)
  • Figure 77. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 78. Latin America Influenza Virus Vaccine (H1N1) Sales Growth Rate Forecast (2021-2026) (K Doses)
  • Figure 79. Latin America Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 80. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Growth Rate Forecast (2021-2026) (K Doses)
  • Figure 81. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 82. Bottom-up and Top-down Approaches for This Report
  • Figure 83. Data Triangulation
  • Figure 84. Key Executives Interviewed
Back to Top